Industrial Purity Manufacturing Process Aprepitant Synthesis Intermediate
Procurement leaders and R&D chemists face critical challenges in securing industrial purity intermediates for complex antiemetic drugs. Supply chain instability and inconsistent analytical verification often delay Aprepitant synthesis timelines. NINGBO INNO PHARMCHEM CO.,LTD. addresses these pain points with validated manufacturing processes and transparent documentation.
Detailed Chemical Synthesis Route and Reaction Mechanism
The production of this critical chiral building block involves a multi-step sequence designed to maximize stereochemical integrity while minimizing defluorinated impurities. The process typically begins with asymmetric hydrogenation or resolution strategies to establish the (R)-configuration essential for biological activity as an NK-1 antagonist precursor. Key reaction stages include catalytic hydrogenation using palladium on carbon under controlled pressure (0.5-5 MPa) and temperature ranges (30-70°C) to ensure selective reduction without compromising the trifluoromethyl groups.
Subsequent coupling reactions utilize precise stoichiometric ratios in solvents such as acetonitrile or tetrahydrofuran to form the morpholine backbone. Rigorous process control during crystallization steps, often employing ethyl acetate and n-hexane systems, removes side products effectively. For detailed market analysis on cost structures, stakeholders often review Wholesale Bulk Price (R)-3,5-Bis(Trifluoromethyl)-Α-Methylbenzyl Alcohol 2026 to align budgeting with production scales. The final isolation of (R)-1-(3,5-Bis-Trifluoromethyl-Phenyl)-Ethanol ensures high optical purity suitable for pharmaceutical-grade applications.
Technical Specifications and Analytical Methods
Quality control relies on validated analytical methods to confirm identity and purity. The following table outlines the critical parameters verified during batch release:
| Parameter | Specification | Analytical Method |
|---|---|---|
| CAS Number | 127852-28-2 | Verification |
| Chemical Name | (R)-3,5-Bis(trifluoromethyl)-α-methylbenzyl Alcohol | NMR/MS |
| Purity (HPLC) | ≥ 99.0% | High Performance Liquid Chromatography |
| Optical Purity | ≥ 98.0% ee | Chiral HPLC |
| Defluorinated Impurity | ≤ 0.1% | LC-MS |
| Residual Solvents | Compliant with ICH Q3C | Gas Chromatography |
Strict Quality Assurance (QA) Workflow and COA Verification Process
At NINGBO INNO PHARMCHEM CO.,LTD., every batch undergoes a stringent QA workflow prior to shipment. This includes raw material inspection, in-process control checks during hydrogenation and coupling, and final product validation. The COA verification process ensures that all analytical data matches the certified specifications, providing procurement teams with the confidence needed for regulatory filings. Documentation includes full traceability from raw materials to the finished intermediate, supporting audit readiness for global pharmaceutical manufacturers.
Our commitment to stable supply and technical excellence ensures that your production lines remain operational without interruption. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.